Brief: Infant Bacterial Therapeutics Q2 Operating Loss Widens To SEK 44.3 Mln
Aug 28 (Reuters) - Infant Bacterial Therapeutics AB
IBTb.ST :
* Q2 NET SALES KSEK 0 (0)
* Q2 OPERATING INCOME KSEK -44 279 (-30 952)
Source text for Eikon: ID:nMFN33wk2L
Further company coverage: IBTb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Infant Bacterial Therapeutics AB
See all newsBrief: Infant Bacterial Therapeutics Gets FDA Request For Type B Pre-BLA Meeting
Brief: Infant Bacterial Therapeutics Q2 Operating Loss Widens To SEK 30.1 Mln
Brief: Infant Bacterial Therapeutics CFO Leaves The Company
Brief: Infant Bacterial Announces Phase III IBP-9414 Study Results
Brief: Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln